MWNA
SRGA

Marshall Wace North America’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Marshall Wace North America’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-512
Closed -$65K – 1638
2019
Q2 		$65K Buy
512
+76
+17% +$10.9K ﹤0.01% 1081
2019
Q1 		$79K Buy
+436
New +$63.1K ﹤0.01% 1164

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's SRGA Position: Q3 2019 in Review

Marshall Wace North America sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2019, closing a stake of 512 shares — an estimated $65K sold.

Marshall Wace North America first reported a position in SRGA in Q1 2019 and held it in 2 quarters. The position peaked at $79K in Q1 2019. 97 funds tracked by Wall St. Rank hold SRGA as of Q3 2019.

  • Marshall Wace North America reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Marshall Wace North America sold 512 Surgalign Holdings, Inc. Common Stock shares in Q3 2019, an estimated $65K.
  • Marshall Wace North America first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Marshall Wace North America's Surgalign Holdings, Inc. Common Stock position peaked at $79K in Q1 2019.
  • 97 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.